Status:
RECRUITING
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
Lead Sponsor:
Columbia University
Collaborating Sponsors:
Varian Medical Systems
Conditions:
Breast Cancer Invasive
Prostate Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study aims to develop educational media interventions to prepare Latinx Spanish-speaking radiation oncology patients for a course of breast or prostate cancer radiation therapy and to foster recep...
Detailed Description
Research suggests that utilization of audiovisual educational interventions may help to address health literacy and language barriers as well as suboptimal outcomes and trial enrollment in minority an...
Eligibility Criteria
Inclusion
- Pilot Phase
- Spanish speakers of Latinx background as defined by the U.S. Census Bureau as anyone from Mexican, Puerto Rican, Cuban, Dominican, Central or South American ancestry
- Currently undergoing treatment for breast or prostate cancer, or recently been treated
- Pilot Phase
Exclusion
- Patient with bilateral deafness and/or blindness
- Patient with psychosis and/or dementia
- Main Study Inclusion Criteria:
- Spanish speakers of Latinx background as defined by the U.S. Census Bureau as anyone from Mexican, Puerto Rican, Cuban, Dominican, Central or South American ancestry
- Patients with non-metastatic prostate or breast cancer
- Histopathologically proven diagnosis of prostate or breast cancer
- History and physical examination within 28 days prior to enrollment
- Karnofsky performance status 70 or greater
- For women of childbearing potential, pregnancy testing to be performed in accordance to institutional guidelines
- Plan to receive definitive, curative radiation. Patients planning to receive curative RT after upcoming adjuvant chemotherapy or induction hormonal therapy may enroll at reconsult "follow-up" visit.
- Consultation visit must be performed with a certified interpreter
- Main Study
Key Trial Info
Start Date :
May 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
194 Patients enrolled
Trial Details
Trial ID
NCT05351424
Start Date
May 3 2022
End Date
December 31 2026
Last Update
April 3 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Medical Center
Miami Beach, Florida, United States, 33140
2
Columbia University Irving Medical Center
New York, New York, United States, 10032